RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1438
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1306200; Gene model (P.falciparum): PF3D7_1442300; Gene product: tRNA import protein tRIP (tRIP)
Transgene
Transgene not Plasmodium: mCherry
Promoter: Gene model: Not available; Gene model (P.falciparum): Not available; Gene product: Not available
3'UTR: Gene model: Not available; Gene product: Not available
Replacement locus: Gene model: PBANKA_1306200; Gene product: tRNA import protein tRIP (tRIP)
Phenotype Asexual bloodstage;
Last modified: 16 April 2016, 21:17
  *RMgm-1438
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 27071116
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherBour T; Ménard R; Frugier M
Name Group/DepartmentArchitecture and Reactivity of RNA
Name InstituteUniversity of Strasbourg, CNRS, Institute for Molecular and Cellular Biology
CityStrasbourg
CountryFrance
Name of the mutant parasite
RMgm numberRMgm-1438
Principal nametRip-KO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stage(Slightly) reduced growth/multiplication of asexual blood stages
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of tRIP and expresses mCherry (promoter unknown)

Protein (function)
A widely distributed tRNA binding motif is exemplified by a minimal tRNA binding protein—Trbp111—that was first identified in Aquifex aeolicus. This free-standing homodimeric protein specifically binds tRNA by recognizing its characteristic elbow structure. Other proteins that contain this motif include the yeast aminoacyl-tRNA synthetase cofactor 1 (ARC1p), the metazoan AIMP1, and Toxoplasma gondii Tg-p43 aminoacyl-tRNA synthetase interacting proteins. The PF3D7_1442300 gene encodes a 402-amino-acid with a Trbp111-orthologous domain at its C terminus and an N-terminal region exhibiting a transmembrane helix motif.

Phenotype
(Slightly) reduced growth/multiplication of asexual blood stages

Additional information
Evidence is presented that tRip (tRNA import protein)—is anchored to the parasite plasma membrane and directs import of exogenous tRNAs. In the absence of tRip, the fitness of the parasite stage that multiplies in the blood is  reduced, indicating that the parasite may need host tRNAs to sustain its own translation and/or as regulatory RNAs.

Evidence is presented for a surface/plasma membrane location of tRIP in merozoites and sporozoites.

In Plasmodium, the causative agent of malaria, the nuclear genome has a minimal set of 45 transfer RNA (tRNA) genes, with only one gene per tRNA isoacceptor. This single-gene feature is an exception among eukaryotes, where tRNA genes are usually present in multiple copies. Discrepancies between codon use and expression levels of corresponding tRNAs were also observed in Plasmodium falciparum blood stages. These considerations raise the possibility that, under at least some conditions, the parasite may need an additional source of tRNAs and possibly rely on the import of exogenous tRNAs.

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1306200
Gene Model P. falciparum ortholog PF3D7_1442300
Gene producttRNA import protein tRIP
Gene product: Alternative nametRIP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasiteunknown
Promoter of the selectable markerunknown
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor replacement of tRip, a 575-bp 5′ fragment (sense: 5′-GGTACCGTGAGCATCTATATATTTGTTCACGTATCATATTTTAAAAATTG-3′; antisense: 5′-CTCGAGGTTGGGGGAATATAATATCGAATATTATATATATGTGTGTA-AATGC-3′) and a 455-bp 3′ fragment (sense: 5′-AGATCTGTTAGTTGGAAAACGAGGTTATTTAGCTCTGTATAATATCGAC-3′; antisense: 5′-GAATTCCTTATCGTTGGTGAAATTGGGAAAATCACCTTCTACCATTGTGCATG-3′) were amplified by PCR using P. berghei genomic DNA as template.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene namemCherry
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasiteunknown
Promoter of the selectable markerunknown
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite Not available
Gene Model P. falciparum ortholog Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_1306200
Gene producttRNA import protein tRIP
Gene product: Alternative nametRIP
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4